The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on Tuesday, April 26, 2016 at the USPTO Headquarters (Alexandria, VA).  The agenda for the meeting is as follows:

• Welcoming and Opening Remarks (10:00 – 10:10 am EST) — Mark Powell, Deputy Commissioner, International Patent Cooperation, USPTO; Jerry Lorengo Director, TC1600, USPTO; Daniel Sullivan Director, TC1600, USPTO; and Wanda Walker Director, TC1600, USPTO

• International Patent Cooperation Featuring Global Dossier (10:10 – 11:00 am) — Jessica Patterson, Program Manager, International Patent Cooperation

• Outside Perspectives on International Patent Cooperation (11:00 – 11:25 am) — Anthony P. Venturino, Vorys, Sater, Seymour and Pease LLP

• Break (11:25 – 11:30 am)

• Supplemental Examination (11:30 am – 12:30 pm) — Jean Witz, SPE, Central Reexamine Art Unit, USPTO

• Lunch (12:30 – 1:30 pm)

• Third Party Submission (1:00 – 2:00 pm EDT) — Bennett Celsa, Quality Assurance Specialist, TC1600, USPTO (Alexandria)

• Antibody Written Description (1:30 – 2:30 pm) — Joanne Hama, SPE, TC1600, USPTO

• Break (2:30 – 2:40 pm)

• Enhancing the Quality of Biologics Patents: Computational Simulations as Evidence (2:40 – 3:40 pm) — Brian Lathrop, Law Office of Brian K. Lathrop

• Closing Remarks (3:40 – 3:50 pm) – Directors, TC1600, USPTO

The meeting can be viewed online here.  Additional information regarding the BCP customer partnership meeting, including registration information for those wishing to attend the meeting, can be found here.